Source: MarketScreener

SynCardia: SynCardia Systems, LLC. 50cc temporary Total Artificial Heart (TAH-t) Now FDA Approved

(marketscreener.com) TUCSON, AZ, March 09, 2020 -- With the FDA approval of the SynCardia Systems, LLC 50cc TAH-t system a greater number of cardiac transplant eligible patients at risk of imminent death from biventricular failure now have access to total artificial heart therapy.The 50cc TAH-t is 37.5% smaller than the 70cc device while maintaining a peak...https://www.marketscreener.com/news/SynCardia-Systems-LLC-50cc-temporary-Total-Artificial-Heart-TAH-t-Now-FDA-Approved--30132237/?utm_medium=RSS&utm_content=20200309

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more